Repligen (RGEN) Interest & Investment Income (2010 - 2026)
Repligen (RGEN) posted quarterly Interest & Investment Income of $6.4 million for Q2 2026, down 2.34% year-over-year from $6.6 million in Q2 2025, and up 1.4% quarter-over-quarter from $6.3 million in Q1 2026.
Repligen (RGEN) Interest & Investment Income (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Interest & Investment Income for 17 consecutive years, with $6.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Interest & Investment Income fell 2.34% year-over-year to $6.4 million; the TTM figure through Jun 2026 stood at $26.4 million (down 15.56% YoY), while the FY2025 annual figure was $27.6 million, down 23.04% from the prior year.
- Interest & Investment Income grew to $6.4 million in Q2 2026 per RGEN's latest filing, from $6.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $9.4 million in Q2 2024 and bottomed at $77000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $6.0 million across 5 years, with a median of $6.5 million in 2025.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 10197.44% — and 2025, when it sank 30.03%.
- Repligen's Interest & Investment Income stood at $4.0 million in 2022, then surged by 49.98% to $6.0 million in 2023, then jumped by 37.69% to $8.3 million in 2024, then decreased by 18.56% to $6.8 million in 2025, then slipped by 4.78% to $6.4 million in 2026.
- Business Quant data shows RGEN's Interest & Investment Income at $6.4 million in Q2 2026, $6.3 million in Q1 2026, and $6.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 4.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 20.89 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 3.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -64.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -64.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 6.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.43 Mn |
| Mar 31, 2026 | 6.34 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 6.92 Mn |
| Jun 30, 2025 | 6.59 Mn |
| Mar 31, 2025 | 7.31 Mn |
| Dec 31, 2024 | 8.29 Mn |
| Sep 30, 2024 | 9.13 Mn |
| Jun 30, 2024 | 9.41 Mn |
| Mar 31, 2024 | 8.99 Mn |
| Dec 31, 2023 | 6.02 Mn |
| Sep 30, 2023 | 6.66 Mn |
| Jun 30, 2023 | 5.96 Mn |
| Mar 31, 2023 | 5.49 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 2.18 Mn |
| Jun 30, 2022 | 708,000.00 |
| Mar 31, 2022 | 77,000.00 |
| Dec 31, 2021 | 39,000.00 |
| Sep 30, 2021 | 44,000.00 |